Sabby Management’s Bone Biologics Corp Warrants BBLGW Stock Holding History

Sabby Management’s Portfolio BBLGW Stock Details BBLGW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,583	Closed	-$4.3K	–	94
2023 Q1	$4.3K	Hold	3,583	–	–	﹤0.01%	89
2022 Q4	$1.89K	Sell	3,583 -33	-0.9%	-$60	﹤0.01%	107
2022 Q3	$9K	Hold	3,616	–	–	0.01%	111
2022 Q2	$16K	Hold	3,616	–	–	0.01%	120
2022 Q1	$37K	Sell	3,616 -1,900	-34%	-$25.3K	0.01%	134
2021 Q4	$116K	Buy	+5,516	New	+$138K	0.02%	152

Other funds holding BBLGW

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sabby Management's BBLGW Position: Q2 2023 in Review

Sabby Management sold out of Bone Biologics Corp Warrants (BBLGW) in Q2 2023, closing a stake of 3,583 shares — an estimated $4.3K sold.

Sabby Management first reported a position in BBLGW in Q4 2021 and held it in 6 quarters. The position peaked at $116K in Q4 2021. 1 fund tracked by Wall St. Rank holds BBLGW as of Q2 2023.

Sabby Management reported no remaining Bone Biologics Corp Warrants position as of Q2 2023 after selling out during the quarter.
Sabby Management sold 3,583 Bone Biologics Corp Warrants shares in Q2 2023, an estimated $4.3K.
Sabby Management first reported a position in Bone Biologics Corp Warrants in Q4 2021 and held it in 6 quarters.
Sabby Management's Bone Biologics Corp Warrants position peaked at $116K in Q4 2021.
1 fund tracked by Wall St. Rank held Bone Biologics Corp Warrants as of Q2 2023.

Based on Sabby Management's 13F filing for Q2 2023, filed 14 Aug 2023.